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Abstract.  From a panel of monoclonal antibodies 
raised against fractions of rat liver nuclear envelopes 
(NEs),  we have identified an antibody, RL30, which 
reacts with novel nuclear pore complex (NPC) anti- 
gens that are not O-glycosylated. By immunofluores- 
cence staining of cultured cells, RL30 reacts exclu- 
sively with the NE in a punctate pattern that largely 
coincides with that of identified NPC proteins.  RL30 
labels only the cytoplasmic surface of the NPC in im- 
munogold electron microscopy, predominantly in pe- 
ripheral regions nearby the cytoplasmic ring.  In immu- 
noblots of isolated rat liver NEs and cultured rat cells, 
RL30 recognizes a 265-kD band,  as well as a  series of 
175-265-kD bands in rat liver NEs that are likely to 
be proteolytic products of p265.  Sequencing of pep- 
tides from the  175- and 265-kD RL30 antigens of rat 
liver revealed that they are both closely related to hu- 
man Tpr,  a protein whose amino-terminal  150-250 
amino acids appear in oncogenic fusions with the ki- 
nase domains of the met, trk,  and raf protooncogenes. 
We found that in vitro translation  of human Tpr 
mRNA yields a major 265-kD band.  Considered to- 
gether, these data indicate that the 265-kD RL30 anti- 
gen in the NPC is the rat homologue of Tpr.  Interest- 
ingly,  Tpr contains an exceptionally long predicted 
coiled coil domain (,x,1600  amino acids).  The localiza- 
tion and predicted structure of Tpr suggest that it is a 
component of the cytoplasmic fibrils of the NPC im- 
plicated in nuclear protein import.  Immunofluores- 
cence microscopy shows that during NPC reassembly 
at the end of mitosis, Tpr becomes concentrated at the 
NE significantly later than O-linked glycoproteins, in- 
cluding p62.  This indicates that reassembly of the 
NPC after mitosis is a stepwise process, and that the 
Tpr-containing  peripheral  structures are assembled 
later than p62. 
N 
'UCLEOCYTOPLASMIC transport is carried out by nu- 
clear pore complexes (NPCs)' (reviewed by Forbes, 
1992; Gerace,  1992; Pant6 and Aebi,  1993; Fabre 
and Hurt, 1994), large supramolecular  structures  that span 
the nuclear envelope  (NE) at regions  where the inner  and 
outer nuclear  membranes  are joined.  The  NPC  contains 
aqueous channels that provide conduits for nonselective pas- 
sive diffusion  of ions,  metabolites, and other small  mole- 
cules (Peters,  1986). Most proteins and RNAs are too large 
to diffuse through these channels  at physiologically  signifi- 
cant rates,  and instead  are actively  transported through  a 
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gated  channel  in  the  NPC  by  selective,  signal-mediated 
mechanisms  (Forbes, 1992; Gerace, 1992; Pant6 and Aebi, 
1993). Signal-mediated transport of macromolecules through 
the NPC is regulated,  and can provide an important  mecha- 
nism  for control  of gene  expression  (reviewed by Gerace, 
1992; Whiteside and Goodbourn,  1993). 
The NPC has dimensions  of ,,o120 x  80 nm and a mass 
of •125  x  106 D  (Reichelt  et al.,  1990).  Its  framework 
consists of a central multidomain "spoke" assembly with pe- 
ripheral  "rings" on the cytoplasmic and nucleoplasmic  sur- 
faces (Hinshaw et al., 1992; Akey and Radermacher,  1993). 
This framework has eightfold rotational  symmetry about an 
axis perpendicular  to the nuclear surface and twofold sym- 
metry about an axis parallel to the NE through the NPC cen- 
ter. A "central channel complex"  (Gerace,  1992) of poorly 
defined architecture  is attached to the inside of the spokes, 
and it contains  a gated channel involved in signal-mediated 
import and export of macromolecules.  Associated with this 
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emanating from both the nucleoplasmic and cytoplasmic 
rings (Jarnik and Aebi, 1991). In isolated amphibian oocyte 
NEs, the nucleoplasmic fibrils, which are '~75-I00 rim long, 
are joined at their distal ends in a "terminal ring," while the 
structurally distinct cytoplasmic fibrils axe <25-50 nm long 
and have no obvious distal connections (Jarnik and Aebi, 
1991; Pant6 and Aebi,  1993). 
Nuclear protein  import is  the best  understood nuclear 
transport pathway. It is specified by short sequences in the 
transported proteins called nuclear localization sequences, 
which are usually enriched in basic amino acids (reviewed 
by Dingwall and Laskey, 1991). Studies involving the use of 
nuclear  localization  sequence-coated  gold  particles  as 
probes  to visualize transport in the EM  (Feldherr et al., 
1984) indicate that an early step in nuclear import involves 
ligand association with the cytoplasmic surface of the NPC, 
which can occur in the absence of ATP and at 0°C (New- 
meyer and Forbes, 1988; Richardson et al., 1988). The ini- 
tial sites of ligand association are suggested to involve the cy- 
toplasmic  fibrils  of the  NPC  (Richardson  et  al.,  1988; 
discussed by Gerace,  1992).  Subsequent transport  steps, 
which are ATP and temperature dependent (Newmeyer and 
Forbes, 1988; Richardson et al., 1988), involve channel gat- 
ing and translocation of ligand to the nucleoplasmic side of 
the NPC. From biochemical analysis of nuclear import with 
in vitro assays, it has become clear that multiple cytosolic 
factors are involved (Adam et al.,  1990;  Newmeyer and 
Forbes, 1990; reviewed by Fabre and Hurt, 1994). To under- 
stand nuclear transport mechanisms, it will be of critical im- 
portance to characterize the structures and proteins of the 
NPC that interact with these cytosolic transport factors and 
the specific steps mediated by these components. 
Currently only a relatively small number of the estimated 
100-200 NPC polypepfides have been characterized in de- 
tail  (reviewed  by Fabre and Hurt,  1994).  In vertebrates, 
these  include  at  least  eight  polypeptides  modified with 
O-linked N-acetylglucosamine (Snow et al., 1987; Davis and 
Blobel, 1987).  The cDNA sequences have been determined 
for three of these O-linked glycoproteins: p62 (Starr et al., 
1990),  Nup153  (Sukegawa  and Blobel,  1993),  and CAN 
(Kraemer et al., 1994), a 214-kD polypeptide characterized 
previously as part of a fusion protein associated with a sub- 
type of myeloid leukemia (von Lindern et al., 1992). At least 
some of  the vertebrate O-linked glycoproteins appear to have 
a direct involvement in mediated transport through the NPC 
(reviewed by Gerace,  1992;  Fabre and Hurt,  1994). 
In this study, we report the characterization of a 265-kD 
protein of rat liver NEs that localizes to the NPC. We discov- 
ered that this protein is a rat homologue of human Tpr, a pro- 
tein that has been previously detected in oncogenic fusions 
with the kinase domains of the trk, met, and raf protoon- 
cogenes (Park et al., 1986; Soman et al., 1991; Greco et al., 
1992).  Tpr contains an exceptionally long predicted coiled- 
coil u-helical region of ~1600 residues beginning near its 
NH2 terminus, flanked by a highly acidic COOH-terminal 
region (Mitchell and Cooper,  1992b).  Using immunogold 
EM, we found that Tpr is localized exclusively to the cyto- 
plasmic surface of the NPC and is concentrated in regions 
near the cytoplasmic ring. The sequence properties and lo- 
calization of Tpr suggest that it is a component of the cyto- 
plasmic fibrils of the NPC, which may be involved in ligand 
docking. During NPC reassembly at the end of mitosis, Tpr 
becomes concentrated at the NE distinctly later than other 
O-linked glycoproteins including p62. This suggests that as- 
sembly of the NPC at the end of mitosis is a stepwise process 
in which peripheral structures containing Tpr assemble after 
the p62 glycoprotein. 
Materials and Methods 
Subcellular Fractionation of Rat Liver 
Unless otherwise noted, all procedures were conducted at 0-4°C. Crude 
NEs were isolated from rat liver as described (Gerace et al., 1984).  To iso- 
late rat liver cytosoi, rat liver homogenate was first centrifuged in a rotor 
(J6B;  Beckman Instruments, Brea, CA) at 2,000 rpm for 10 rain to yield 
a low speed supernatant. The latter was next centrifuged in a Beckman JA20 
rotor at 10,000 rpm for 30 rain to yield an intermediate speed supernatant. 
This superuatant was then centrifuged in a Beckman Ti45 rotor for 1 h at 
40,000 rpm, yielding a supernatant comprising the rat liver cytosol fraction. 
The microsomal membrane fraction was prepared as described (Gerace et 
al., 1982). Protein concentrations for the various subcellular fractions ana- 
lyzed in Fig. 1 were determined with a protein assay kit (Bio Pad Laborato- 
ries, Hercules, CA). 
Crude NEs were fractionated by washing with 500 mM NaCl (Snow et 
al.,  1987).  Salt-washed NEs were extracted with 8 M urea as previously 
described (Foisner and Gerace,  1993).  To solubilize NE proteins for im- 
munoadsorption, salt washed NEs were resuspended at 100 OD U/mi (10D 
U of NEs is the amount derived from 10D2~0 of nuclei) in S buffer (50 
mM Tris, pH 8.8, 500 mM NaCI, 2% Triton X-100, 10 mM EDTA, 1 mM 
DTT,  1 mM PMSF, and 1 t~g/rnl each of leupeptin, peI:statin, and aproti- 
nin), incubated on ice for 30 min, and ultracentrifuged for 20 rain at 65,000 
rpm in a Beckman TLAI00.2 rotor to yield a supernatant of solubilized pro- 
teins that was used directly for immunoadsorption (see below). 
Cell Culture and Labeling 
Normal rat kidney (NRK) and HeLa cells were grown at 37°C in Dulbecco's 
modified Eagle's medium (GIBCO BRL,  Gaithersburg, MD) containing 
10% fetal calf serum,  100 U/ml penicillin, and 100/~g/ml streptomycin. 
CHO cells were grown in Joklik's modified minimal essential medium 
(Gibco-BRL) containing nonessential amino acids,  10% fetal calf serum, 
and penicillin/streptomycin. For immunoadsorption, cells were grown to 
75-90%  confluency in lO-cm tissue culture dishes. Dishes were washed 
once in ice-cold PBS (40 mM NaCI and 10 mM sodium phosphate, pH 7.4) 
and cells were lysed in the dish by adding 1 ml of ice-cold S buffer (see 
above). The lysed cells were harvested with a rubber spatula, transferred 
to a microfuge tube, gently sonicated for 10 s, incubated on ice for another 
30 rain, and then centrifuged in a Beckman TLAI00.2 rotor for 20 rain at 
65,000  rpm,  yielding a  supernatant  of solubilized cell  protein for im- 
munoadsorption. 
Metabolically labeled NRK cells were obtained by washing 10-cm plates 
grown to  75-90%  confluency twice with methionine-deficient medium 
(ICN  Biomedicals Inc.,  Irvine,  CA),  incubating the cells in  the same 
medium for 30 rain in a 37"C cell culture incubator, and then replacing the 
medium with 4  ml of methionine-deficient medium containing Tran3ss- 
label (ICN Biomedicals) at 0.5 mCi/ml. The cells were again incubated for 
30 rain in a 370C incubator, the radioactive medium was removed, and the 
cells were solubilized as described above. 
Antibody Production 
The RL30 hybridoma line, which secretes antibodies against ~pr, was ob- 
tained  by  immunizing Armenian hamsters with an  O-linked glycopro- 
tein-enriched fraction of rat liver NEs and fusing the spleen cells of these 
animals with a mouse myeloma cell line as described (Foisner and Gerace, 
1993).  To  obtain RL30  culture  supernatant,  the RL30  hybridoma was 
grown in EXCELL 300 serum-free medium (JRH Biosciences, Lenexa, KS) 
supplemented  with  penicillin  and  streptomycin.  The  supernatant  was 
cleared of cells and cell debris by spinning the culture in a Beckman I6B 
rotor at 5,000 rpm for 20 min. Solid ammonium sulfate was slowly added 
to the supernatant to a final concentration of  55 % and precipitated overnight 
at  4°C.  The  precipitated  antibodies  were  pelleted,  and  pellets  were 
resuspended in ice-cold PBS + 0.02%  NaN3 and were dialyzed against this 
buffer overnight with three changes. The RL30 antibodies in the concen- 
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G or GammaBind-Plus immuneaffinity columns (Pharmacia Biotech, Pis- 
caraway, NJ), which were washed with PBS and eluted with 200 mM gly- 
cine, pH 2.2 or 2.7,  respectively. The eluant was immediately dialyzed 
against PBS +  NaN3 overnight with three changes, and was concentrated 
in a colloidian apparatus with 25,000 mol wt cutoff membrane (Sehleieher 
&  Sehuell, Inc., Keenc, NH). 
Rabbit polyclonal antibodies specific for rat 1Ri2 have been characterized 
previously (see Fig. 4 in Snow et al.,  1987).  For the experiments in this 
paper, the antibodies were affinity-purified on a column of recombinant rat 
p62 obtained by expression in Escherichia  coli,  instead of using the p62 
band excised from an immunoblot as described previously (Snow et al., 
1987).  Recombinant p62 was provided by Bryce Paschal (The Scripps Re- 
search Institute, La Jolla, CA), who expressed it using a p62 eDNA ob- 
tained from John Hanover (Laboratory of Biochemistry and Metabolism, 
National  Institute of Diabetes and Digestive and Kidney Diseases, Be- 
thesda, MD) (Starr et al.,  1990). 
Immunoadsorption, SDS Gel Electrophoresis, 
and Iramunoblotting 
To prepare a solid-phase RL30 immunoadsorbent, purified RL30 antibodies 
were dialyzed and concentrated against coupling buffer consisting of 200 
mM sodium carbonate, pH 8.9, and 500 mM NaCI, and then coupled to 
cyanogen bromide-activated Sepbarose 4B (Pharmacia Biotech) at a ratio 
of 4 nag of antibody/nil of beads according to the manufacturer's instruc- 
dons. After blocking with 100 mM ethanolamine, the beads were washed 
three times in PBS  +  0.02 % NaN3 and stored at 40C.  15  txl of RL30- 
Sepharose were prewashed in 500 #l S buffer and then incubated overnight 
with either 1 ml of whole cell iysate or 100 ODs of solubilized salt washed 
NEs (see above). The beads were then washed three times in S buffer, once 
in S buffer without Triton X-100, and eluted in SDS gel sample buffer con- 
taining 100 mM DTT for 10 rain at 37"C. 
Samples of s ubcellular fractions and immtmoadsorbed proteins were 
separated on either precast 4-15% gradient SDS polyacrylamide gels (Bio 
Rad Laboratories) or on 5% SDS polyacrylarnide gels, using the sample 
preparation conditions described previously (Gerace et al., 1982).  For im- 
munoblotting, proteins in gels were electrophoretically transferred onto 
supported nitrocellulose (Micron Separations Inc., Westborongh, MA). 
These blots were blocked in TBST  (50 mM Tris-HCl, pH 7.9,  150 mM 
NaCI, and 0.05% Twcen 20) containing 2% BSA (TBST-BSA)  for 1 h at 
room temperature, and were then incubated with primary antibody solu- 
tions for 1 h at room temperature or overnight at 4°C. Primary antibodies 
were all diluted in TBST-BSA buffer and consisted of either purified RL30 
at a concentration of 5 t~g/ml, RL1 ascites, or human autoimmune patient 
serum No.  30 diluted t:500, or rabbit polyelonal antipeptide sera raised 
against the human "I~r peptide LNKLPKSVQNKLE (comprising residues 
14-26)  diluted 1:200.  After primary antibody incubations, the blots were 
washed three times for 5 rain in TBST-BSA, and then incubated for 1 h at 
room temperature with alkaline phosphatase-coupled goat anti-human, 
goat anti-mouse IgG,  and goat anti-rabbit antibodies (Promega Corp., 
Madison, W1) all diluted 1:4,000 in TBST-BSA.  Since the goat anti-mouse 
antibodies obtained from Promega cross-reacted with the RL30 Armenian 
hamster antibodies, no mouse anti-hamster bridge antibody was required. 
After secondary antibody incubations, the blots were washed three times 
for 5 min in "rBST and once in TBST lacking Tween 20, and were then de- 
veloped with nitroblue tetrazolium/bromnchloroinodyl phosphate alkaline 
phosphatase buffer as described (Harlow and Lane, 1988). The colorimetric 
reactions were stopped by extensive washing of the blots with water. 
Peptide Sequencing 
To obtain peptide sequences, RL30 antigens were immunoadsorbed from 
4000  ODs  of rat  liver NEs  and  were electrophoresed on a  5%  SDS- 
polyacrylamide gel. The proteins contained in the gel were then electropho- 
retically  transferred onto  an  Immobilon polyvinyldifluoride membrane 
(Millipore Corp., Bedford, MA) overnight at 4°C in buffer containing 100 
mM Tris, pH 8.8, and 100 mM boric acid. The blot was stained with 0.1% 
Ponceau S in 1% acetic acid, and indicator strips were removed and ana- 
lyzed by immunoblotting with RL30 as described above. Horizontal strips 
of the membrane corresponding to the p175 and p265 bands were excised 
and digested with endoproteirmse Lys C  (Sigma Immunochemieals, St. 
Louis, MO). The peptides then were eluted from the membrane and sepa- 
rated on a Cts reversed-phase HPLC column. Seven peak fractions were 
subjected to automated Edman degradation on a sequencer (model 4777A; 
Applied Biosystems, Inc., Foster City, CA) equipped with an in-line PTH 
analyzer (model 120A; Applied Biosystems). Paptide sequences obtained 
were used to search the G-enEMBL database using the TFASTA search pro- 
gram  (Genetics  Computer  Group,  Madison,  WI).  Protease  digestion, 
HPLC purification, and peptide sequencing were carried out by Dr. John 
Leszyk (Protein Chemistry Facility,  Worcester Foundation for Experimen- 
tal Biology,  Worcester, MA). 
Construction and Expression of FuU-length Tpr 
A  full-length Tpr cDNA was assembled from three partial length cDNA 
clones: ),HT5, hHT9, and M-IT14 (Mitchell and Cooper, 1992b).  First, the 
BstXI site in the multiple cloning site of pBluescript-SK was destroyed by 
digesting with BstXI, carrying out 5'-3' exonuelease digestion with Klanow 
fragment, and religating the plasmid. The 2.5-kb Eagl-EcoRI fragment 
from the 5' partial-length eDNA MtT5 was subcloned into the BstXl-lack- 
ing pBlueseript-SK and renamed pH "15. Two complementary oligonucleo- 
tides which code for an amino terminal c-myc epitope with the sequences 
5 '-  CGACA~GAGC~GCAAAAAC TTATTIC TGAAGAGGAC  TW_~  T- 
TAAGGG-3' and 3'-TACCGTCTCC'IUGT/'TIq'GAATAAAGACTTCTCC- 
TGAACGAATICCCGCTG-5' were annealed and inserted into the eDNA 
BstXl site at nueleotide 294, resulting in the plasmid pMycS, which was se- 
quenced to confirm the orientation and fidelity of the oligonucleotide insert. 
M-ITI4, which contains a 4.5-kb 3' partial-length cDNA for Tpr, was double 
digested with NotI, which has a single site in the vector, and Pspl406I, which 
cuts the eDNA at nucleodde 4296. pMyc5 gas cut with NotI in the multiple 
cloning site and with Pspl406I at nucleotide 2466, releasing a 2.2-kb eDNA 
fragment that was ligated into the NotI-Psp1406I  linearized XHTI4, resulting 
in pMyc5q4. The 1.8-kb Pspl406I eDNA fragment from M-I'I9 was ligated 
into pMyc5q4, which was linearized with Pspl406I,  resulting in the full- 
length construct pMyc'l~r. "1"7  promoter, Sail, and KpnI sequences were intro- 
duced into pMyc~r by annealing and ligating the complementary oligos TT1, 
5'-GGCCTAATACCxACqCACTATAGGGTCGACGG  TACCGC-3', and T72, 
3'-ATTAaUJC'IUtAG'IGATATCCCAGC'IGCCA'IGGCGCCGG-5',  into  the 
Nod site of pMyeTpr. Sequencing confirmed the orientation and fidelity of 
the oligonueleotides.  The correct construct was called pT7Tpr and was used 
for in vitro translation. 
For DNA sequencing and in vitro transcription/translation of the full- 
length Tpr construct, pT7Tpr  plasmid DNA was purified using the Maxi- 
Prep Kit (QIAGEN Inc., Chatsworth, CA). DNA sequencing was carried 
out using a PRISM  TM  cycle sequencing kit and the model 373A DNA se- 
quencing system (Applied Biosystems). The sequence around the originally 
predicted stop codon was determined by first subcloning two fragments of 
Tpr eDNA  [XbaI(6415)-HindlLI(7496)  and NsiI(4458)-SphI(6620)]  into 
pBlueseript-SK+ (Stratagene, La Jolla, CA) and sequencing using M13 re- 
verse and forward primers, respectively. For in vitro translation, the full- 
length construct with the T7 RNA polymerase promoter was used in the 
TnT T7 coupled reticulocyte lysate system (Promaga).  1.5 t~g of purified 
pT'/Tpr plasmid DNA was used in a 50-tzl reaction with tran3~S-label.  40 
tA of the reaction was loaded on the 5 % SDS-PAGE gel shown in Fig. 3 b. 
Immunofluorescence Microscopy 
NRK or HeLa cells were grown as described above on No.  1 coverslips. 
The coverslips were washed twice in PBS, fixed for 5 min in PBS containing 
1.1  or 4%  paraformaldohyde for visualizing interphase or mitotic cells, 
respectively, washed three times with PBS, and then permeabilized for 6 
min  in PBS  +  0.2%  Triton  X-100.  After permeabilization,  they were 
washed three times with PBS and twice with PBS +  0.2% gelatin (PBS-G). 
For detection of the RL30 Armenian hamster antibodies in immunofluohes- 
cence microscopy, purified mouse monoclonal anti-hamster IgG, RG7/7, 
was used as a  bridge antibody. For double immunofluorescence experi- 
ments, primary  antibody solutions (all  in PBS-G) consisted of purified 
RL30 antibodies at 20 #g/ml, purified RG'//7 at 2 t~g/ml, and either mouse 
IgM RL1 ascites diluted 1:500,  rabbit anti-lamin serum diluted 1:400,  or 
afffinity-purified rabbit anti-p62 antibodies. The eoverslips were incubated 
with the primary antibody solutions for 30 min at room temperature in a 
humidified chamber. The eoverslips were then washed three times with PBS 
and twice with PBS-G. The secondary antibody solutions (all  in PBS-G) 
contained rhodamine-coupled, afffinity-purified  goat anti-mouse IgG di- 
luted 1:200  and either fluorescein-coupled, affinity-purified donkey anti- 
rabbit antibodies at  1:100 or  fluorescein-coupled, affinity-purified goat 
anti-mouse IgM diluted 1:100. All secondary antibodies were from Jackson 
Immunoresearch, Inc.  (West Grove, PAL  The eoverslips were incubated 
with the secondary antibodies for 30 min, and were washed twice with PBS, 
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glycerol, and SlowFade antifade agent (Molecular Probes, Inc., Eugene, 
OR). Samples were examined with an Axiophot microscope (Carl Zeiss, 
Inc., Thornwood, NY) or a laser scanning  confocal  microscope  (MRC-600; 
Bio-Rad). 
Immunogold Electron Microscopy 
Colloidal gold particles, '~8 nm in diameter, were prepared by reduction 
of tetrachloroauric acid with sodium citrate in the presence of tannic acid 
(Slot and Geuze, 1985). The monoclonal antobody RL30 was conjugated 
to colloidal gold particles as described by Baschong and Wrigley (1990). 
After conjugation,  the complexes  were dialyzed  agains PBS and centrifuged 
at 45,000 g for 15 min. The soft pellet was resaspended in STM buffer (10 % 
sucrose, 10 mM Hepes, pH 7.4, 1 mM MgCI2, and 1 mM DTT) and used 
for labeling rat liver NEs. 
For  immunngold labeling, pellets of crude  rat  liver  NEs  were re- 
suspended in STM buffer at about 50 OD/ml, and the gold-conjugated 
RL30 was added to this suspension at a final concentration of '~5/~g/ml. 
After incubation for 1 h at room temperature, the labeled NEs were salt 
washed by adding an equal volume of STM buffer containing 1 M NaCI, 
followed  by centrifugation  for 5 min in an Eppendorf microfuge  at 5,000 g. 
The pellets of NEs were then washed very gently (without further centrifu- 
gation) three times for 10 rain each with STM buffer containing 1% BSA. 
After immunogold labeling and washing, samples were fixed with 2 % 
glutaraldehyde  in PBS at 4"C for 30 min, washed  three times with cold PBS, 
and postfixed  for 1 h with 1% OsO4 in PBS at 4°C. Next  the samples were 
dehydrated  and embedded  in Epon 812 resin as described  by Jarnik and Aebi 
(1991). Thin sections  were cut on a microtome (Ultracut; Reichert-Jung  Op- 
tische Werke, Vienna, Austria) using a diamond knife. The sections were 
collected on carbon/colloidon-coated  EM grids, stained with 6% uranyl 
acetate for 45 min, and poststained with 2 % lead citrate for 1 min (Millon- 
ing, 1961). Specimens  were examined  under a transmission  electron micro- 
scope (H-8000; Hitachi Scientific  Instruments, Mountain View, CA) oper- 
ated at an acceleration voltage of 75 kV. Micrographs were recorded on 
SO-163 film (Eastman Kodak Co., Rochester, NY). Magnification  calibra- 
tion was performed according to Wrigley (1968) using negatively stained 
catalase crystals. 
Results 
A Monoclonal Antibody That Recognizes a Group of 
Novel Nuclear Envelope Antigens 
From a panel of monoclonal antibodies against fractions of 
rat liver NEs (see Materials and Methods), we identified one 
antibody, RL30, that appeared to react specifically with the 
NPC  in immunofluorescence microscopy (see below).  On 
immunoblots of isolated rat liver NEs,  RL30  recognized a 
group of  bands migrating between 175 and 265 kD, including 
major bands at "~175 kD (p175), 225 kD, and 265 kD (p265) 
(Fig. 1, lanes 5). These bands were observed in a large num- 
ber of different rat liver NE preparations and experiments, 
Figure 2.  Immunoblot analysis of RL30 antigens. Fractions ana- 
lyzed are salt-washed rat liver NEs (lanes 1 ), RL30 antigens im- 
munoadsorbed from solubilized rat liver NEs (lanes 2), and RL30 
antigen immunoadsorbed from solubilized NRK cells (lanes 3). 
Immunoblots of these fractions were probed with RL30 (A), RL1 
(B), human autoimmune serum No. 30 (C), and a polyclonal anti- 
body against residues  14-26  of human  Tpr  (D).  All of the  im- 
munoreactivity shown in D  was abolished by including a peptide 
containing residues 14-26 of Tpr in the primary antibody incuba- 
tion (data not shown). 
although additional immunoreactive bands in the  175-265- 
kD region were obtained frequently. The relative proportion 
of the three major antigens detected by immunoblotting var- 
ied with different preparations. In some cases (Fig. 1), p175 
was  apparently more  abundant  than  p265,  while  in  other 
cases (Fig. 2), they were equally abundant. As discussed fur- 
ther below, it is likely that most or all of the RL30 antigens 
migrating faster than the 265-kD band from rat liver NEs are 
produced by in vivo and/or in vitro proteolysis of p265. 
The major RL30 antigens were highly enriched in isolated 
NEs  in  comparison to  other  subeellular  fractions.  While 
they  were  readily  detected  in  isolated  NEs  by  immuno- 
blotting (Fig.  1,  lanes 5),  they were undetectable in cyto- 
sol,  microsomal membranes,  isolated nuclei,  or DNAase- 
released nuclear contents (Fig.  1, lanes 1-4). RL30 reacted 
weakly with an •40-kD  band enriched in the cytosol frac- 
tion (Fig. 1), but its relationship to the 175-265-kD NE anti- 
gens is unknown.  The RL30  antigens of NEs were tightly 
envelope-associated, as they were not substantially released 
into a  supernatant by extraction with 0.5  M  NaC1,  which 
solubilizes most contaminating chromatin  (Fig.  1,  lanes 6 
and  7)  (Snow et al.,  1987).  However, when  NEs  were ex- 
tracted with 8  M  urea, the RL30 antigens were completely 
solubilized (Fig.  1, lanes 8  and 9),  indicating that they are 
peripheral membrane proteins of the NE. 
The multiple 175-265-kD  RL30-reactive bands detected 
in unfractionated rat liver NEs by immunoblotting were all 
immunoadsorbed  by  RL30  from  NEs  solubilized in  Tri- 
Figure 1.  Distribution of Tpr in subcellular frac- 
tions of rat liver. Samples of subcellular fractions 
of rat liver were separated on a 4-15%  gradient 
SDS polyacrylamide gel and analyzed by staining 
with Coomassie blue (A) or immunoblotting with 
the  RL30  monoclonal antibody (B).  Lanes 1-4 
contain 50 #g of the following samples: cytosol 
(lanes 1 ), microsomal membranes (lanes 2), iso- 
lated  nuclei  (lanes  3),  and  nuclear  contents 
released from nuclei by nuclease digestion at low 
ionic strength (lanes 4). Lanes 5-9 contain '~4.5 
x  107 nuclear equivalents of crude NEs (lanes 5), the supernatant derived from extraction of crude NEs with 0.5 M NaCI (lanes 6), 
the pellet of 0.5  M NaCl-washed NEs (lanes 7), the supernatant from extraction of salt-washed NEs with 8 M urea (lanes 8), and the 
pellet from extraction of NEs with 8 M urea (lanes 9). Migrations of molecular mass standards are indicated on the left, and migrations 
of the p175 and p265  RL30 antigens are indicated on the right. 
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relative amount of p175 increased relative to the upper bands 
during the immunoadsorption, presumably as a result of in 
vitro degradation.  By contrast, when RL30 antigens were 
immunoadsorbed from a cultured rat cell line (NRK cells), 
a predominant doublet near 265 kD (Fig 2 A, lane 3) or a 
single 265-kD band (Fig. 3) were detected, together with mi- 
nor faster migrating bands.  RL30 did not recognize cross- 
reacting antigens in CHO (hamster) and HeLa (human) cup 
tured  cells  by  immunoblotting  or  immunofluorescence 
microscopy (data not shown). 
A number of  experiments indicated that the RL30 antigens 
did not correspond to previously characterized NPC poly- 
peptides. The immunoadsorbed RL30 antigens from rat liver 
and normal rat kidney (NRK) cells were not recognized by 
the RL1  monoclonal antibody (Fig.  2  B,  lanes 2  and 3), 
which reacts with a group of eight O-glycosylated NPC pro- 
teins (Snow et al.,  1987). These include prominent bands 
migrating near 180 and 210 kD (Snow et al.,  1987), which 
apparently correspond to Nup153  (Sukegawa and Blobel, 
1993) and CAN (Kraemer et al.,  1994), respectively, based 
on the gel mobility. Moreover, the rat liver RL30 antigens 
were not bound to wheat germ agglutinin-Sepharose (data 
not shown), which also recognizes the O-linked NPC glyco- 
proteins,  or  to  lentil  lectin-Sepharose (data  not  shown), 
which  binds  to  N-glycosylated proteins,  including  gp210 
(Gerace et al., 1982). Interestingly, we found that the RL30 
antigens were relatively prominent human autoimmune anti- 
gens. In a collection of 55 human autoimmune sera that react 
with the NE by immunofluorescence microscopy (Konstan- 
A  ]~IAI~ocL Sequence 
6561  ~  ~  ~  ~  ~  T~  ~ 
M  T  R  $  S  L  2094 
~r~ectecL Sere 
6561  ,k_~L'G  J~  C~-,JL J~  CJ~  'JL~"~ CG'JP ,~  J~ 
Ill  T  It  It  Q  8  V  G  It  2097 
Figure 3. Corrected eDNA sequence of human Tpr near the origi- 
nally predicted stop eodon. (A) The top line shows the originally 
published eDNA and amino acid sequences near the predicted stop 
eodon. The bottom line shows the corrected eDNA sequence, con- 
taining the insertion of a guanine nueleotide at nueleotide 6571. 
This results in an open reading frame that extends another 258 
residues. (B) Lane I shows a sample immunoadsorbed from meta- 
bolically  labeled  NRK  cells  with  RL30, in  which  p265  pre- 
dominates. Lane 2 shows radiolabeled products from in vitro trans- 
lation of a  full-length eDNA  from human Tpr, where  a  major 
265-kD band is apparent. 
tinov et al., 1995), nine sera were found to react specifically 
with the group of antigens immunoadsorbed by RL30 (e.g., 
Fig. 2  C). 
Homology of the Rat Liver RL30 Antigens to 
Human I~r 
To further characterize the RL30 antigens,  we immunoad- 
sorbed the  proteins from rat liver NEs  and  obtained  se- 
quences of peptides from the p175 and p265 bands (Table I; 
see Materials and Methods). Seven peptide sequences were 
obtained, five from p175 and two from p265 (Table I). All 
seven peptides were highly homologous to regions between 
residues 125 and 1518 of the predicted amino acid sequence 
of the human  translocated promoter region  (Tpr) protein 
(Mitchell and Cooper, 1992b). The HPLC profiles of  proteo- 
lytic digests of p175 and p265 used for peptide sequencing 
were very similar (data not shown), further suggesting that 
the two bands are closely related structurally. In addition, 
polyclonal antibodies  raised  against  a  peptide comprising 
residues  14-26 of human Tpr reacted with the same bands 
as RL30 in rat liver NEs and a  sample of immunoisolated 
RL30 antigens (Fig. 2 D). Considered together, these results 
indicate that p175 and p265 are different forms of a rat homo- 
logue of human Tpr. 
The published sequence of human Tpr eDNA predicts an 
open reading  frame  (ORF1)  encoding 2094  amino  acids, 
Table L  Comparison  of Amino Acid Sequences  of 
Peptides from Rat RL30 Antigens with Predicted Amino 
Acid Sequences from Human Tpr cDNA 
Source of  Human Tpr 
peptide  Amino acid sequence  amino acid No. 
Rat p175 
Rat p265 
XDLIXTNEXLXSEVEYL 
III  III  I  I:111 
RDLIRTNERLSQELEYL 
LQFQVEILTK 
II  I  I 
LQKHVEDLLTK 
LLXEK 
III 
LLLEK 
LGGQNILLK 
II  :111 
QRGQNLLLK 
VIQQLNEEVGRLK 
III  :11:1111 
RIQQLTEEIGRLK 
LSEVRLSQQRESLLA 
IIII  IIIIIIIIII 
LSEVRLSQQRESLLA 
TLSEKETEARXLQEQTAQL 
IIII  IIIII  IIII1:11 
TLSEKETEARNLQEQTVQL 
125-141 
250-260 
409-414 
809-817 
1367-1379 
793-807 
1503-1518 
X, unassignable;., uncertain  assignment; I, identical; :, conservative  substi- 
tution. 
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Cooper,  1992b).  However,  a  second distinct 299  residue 
ORF (ORF2) occurs at the 3' end of the eDNA, which ex- 
tends  254  amino acids  beyond the predicted  stop  codon 
(Mitchell and Cooper, 1992b). In vitro translation of 3' trun- 
cations of a Tpr eDNA segment (beginning at codon 1745 
and  extending up  to  589  nucleotides  downstream of the 
predicted stop at codon 2094) indicated that the actual trans- 
lation  stop  site  of Tpr  was  >t20 kD  downstream  of the 
predicted stop (data not shown). Therefore, we resequenced 
the region surrounding the putative stop codon in a partial 
length eDNA clone containing this 3' region (Mitchell and 
Cooper, 1992b). From this, we identified a sequencing error 
in codon 2092 of Tpr (Fig. 3 A), which introduces a one- 
nucleotide frameshift and results in a predicted stop three 
codons later. The corrected sequence in codon 2092 (Fig. 3 
A) places ORF2 in frame with the main portion of Tpr, add- 
ing 258 residues of ORF2 onto the first 2091  amino acids 
of the previously described Tpr. With this correction, Tpr is 
now  predicted  to  encode  a  2349-residue  protein  with  a 
predicted molecular mass of  265,559 D, which is close to the 
observed mobility of p265. 
To directly investigate whether rat p265 comigrates with 
full-length Tpr, we assembled a full-length eDNA from three 
partial length clones, and we inserted a T7 RNA polymerase 
promoter and c-myc tag at the 5' end of the full-length con- 
struct (see Materials and Methods). This construct was tran- 
scribed and translated in vitro with T7 RNA polymerase and 
reticulocyte lysate, and the size of the translation product 
was compared with the mobility of p265 immunoadsorbed 
from metabolically labeled NRK (normal rat kidney) ceils. 
As shown in Fig. 3 B, p265 from the radiolabeled NRK cells 
comigrated with the largest and most abundant translation 
product. Moreover, when the Tpr eDNA with the c-myc tag 
was expressed in vivo in BHK cells using the vaccinia T7 
RNA polymerase system, the largest product recognized by 
an anti-myc monoclonal antibody was a 265-kD band (data 
not  shown).  From these data,  we conclude that the  Tpr 
eDNA encodes a 265-kD protein, which corresponds to the 
265-kD band of rat liver NEs and NRK cells recognized by 
RL30. Since all RL30-reactive bands migrating faster than 
p265 in rat liver NEs contain a Tpr epitope corresponding 
to residues 14-26 of human Tpr, these bands probably arise 
from proteolytic removal of different portions of the acidic 
COOH-terminal tail of the 265-kD full-length Tpr. This in- 
terpretation is consistent with the presence in this domain of 
several regions containing repeating PEST sequence motifs 
(Mitchell and Cooper,  1992b),  which give rise to elevated 
protease sensitivity (Rogers  et al.,  1986). 
Tpr Localization  to the Cytoplasmic  Surface of the 
Nuclear Pore Complex 
In immunofluorescence microscopy of NRK cells, RL30 la- 
beled the NE exclusively (Fig. 4). This was most clearly seen 
in confocal images near the nuclear equator, where all im- 
munoreactivity occured at the nuclear"rim" (Fig. 4 E), simi- 
lar to the labeling obtained with RL1 (Fig. 4 F), an antibody 
that reacts with O-linked glycoproteins of the NPC (Snow et 
al., 1987). In optical sections containing the nuclear surface, 
RL30 gave discontinuous punctate labeling of the NE (Fig. 
4 A) that largely colocaiized with RL1 staining (Fig. 4 B). 
Figure 4. Localization of RL30 antigens in cultured rat NRK cells 
by immunofluorescence  microscopy. NRK cells were fixed with 
formaldehyde,  permeabilized with Triton X-100, and processed for 
double immunofluorescence  labeling with RL30 and RL1 (A and 
B, respectively,  and E and F,, respectively)  and RL30 and polyclonal 
anti-lamins A and C (C and D, respectively). Micrographs of nu- 
clear surfaces (A-D) were taken with a conventional epifluores- 
cence microscope, while images of equatorial regions of nuclei (E 
and F) were obtained with a confocal laser scanning microscope. 
Bar, 5/~m. 
By contrast, the discontinuous RL30 labeling (Fig. 4 C) was 
distinct from the largely continuous labeling of the nuclear 
surface obtained with a polyclonai antibody to nuclear la- 
mins  (Fig.  4  D).  Immunofluorescence labeling of human 
HEp-2 cells with several autoantibodies directed against the 
RL30 antigens (including the antibody characterized in Fig. 
2 C) gave an essentially identical immunofluorescence  local- 
ization pattern  (data not shown).  Hence,  immunofluores- 
cence microscopy indicates that Tpr is specifically localized 
to the NPC. 
To examine the localization of RL30 antigens at higher 
resolution, we performed immunogold electron microscopy 
on isolated rat liver NEs with gold-conjugated RL30.  As 
shown in Fig. 5, RL30 strongly and specifically labeled the 
NPC, and did not significantly decorate the lamina or other 
membrane components.  Furthermore, RL30-gold labeling 
was found exclusively on the cytoplasmic surface of the NPC 
and was absent from the nucleoplasmic surface. The labeling 
was concentrated nearby and peripheral to the cytoplasmic 
ring, although labeling was occasionally seen in more central 
NPC regions (Fig. 5). This pattern of labeling is consistent 
with Tpr being part of the fibrils that emanate from the cyto- 
plasmic ring of the NPC, which are occasionally bent and 
extend towards  the  center  of the pore  (Jarnik  and Aebi, 
1991).  Taken  together, the results of immunofluorescence 
The Journal of Cell Biology, Volume  127, 1994  1520 Figure 5. Localization of RL30 antigens in isolated rat liver nuclear envelopes by immunogold electron microscopy. Isolated nuclear enve- 
lopes were fixed, incubated with RL30-gold conjugates, embedded, and examined by thin section electron microscopy (see Materials and 
Methods). Shown are several views along single NEs, as well as a gallery of selected NPCs, to depict typical patterns of gold labeling 
obtained in areas containing well-preserved NPCs. The nucleoplasmic (n) and cytoplasmic (c) surfaces of the NE are indicated in the 
top and right images. The two nuclear membranes can be readily distingifished in these preparations because the outer nuclear membrane, 
unlike the inner membrane, is frequently ruptured. 
and immunoelectron microscopy plus subcellular fraction- 
ation demonstratethat Tpr is a component of the NPC re- 
stricted to its cytoplasmic surface. 
Late Assembly of Tpr in the Nuclear Envelope at the 
End of  Mitosis 
During mitosis, the NPC is disassembled at the ultrastruc- 
tural level and component proteins are dispersed throughout 
the cytoplasm, as can be visualized by immunofluorescence 
microscopy of cultured cells (Forbes, 1992; Gerace, 1992). 
The NPC reassembles in the NE at the end of mitosis, when 
NPCs  are inserted into  the continuous double membrane 
surrounding chromatin masses.  As illustrated in Fig.  6, in 
double immunofluorescence staining of mitotic NRK cells 
with RL1  and RL30, both groups of antigens became dis- 
persed more or less diffusely throughout the cytoplasm in 
late prophase at the time of NE disassembly, and remained 
in  a  dispersed  state throughout metaphase and  anaphase. 
However, ia late anaphase and early telophase when nuclear 
membranes  are  reassembled  around  mitotic  chromsomes 
(Foisner and Gerace, 1993), RL1 antigens became progres- 
sively concentrated around the periphery of the chromo- 
somes, while RL30 antigens remained dispersed throughout 
the cytoplasm (Fig. 6). Almost all of the RL1 antigens were 
concentrated at the chromosome surfaces before detectable 
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ization of RL30 and RL1 antigens at the end of 
mitosis.  NRK cells were processed for double 
immunofluorescence staining as in Fig. 4. Fluo- 
rescent  and  phase contrast  images of cells  in 
metaphase and  progressive stages of early-late 
telophase are shown. Bar, 5 #m. 
accumulation of RL30 antigens, which occurred only during 
mid-late telophase (Fig. 6). Similar results were obtained in 
double immunofluorescence staining of cells with RL30 and 
a polyclonal antibody that is monospecific for p62,  one of 
the eight glycoproteins recognized by RL1 (Fig. 7). As be- 
fore,  most  RL30  antigens  became  concentrated  at  the 
reforming NE after p62. These data suggest that assembly 
of  the NPC is a stepwise process in which Tpr-containing pe- 
ripheral structures assemble after other components, includ- 
ing p62. 
Discussion 
A Rat Homologue of  Human Tpr 
Using the RL30 monoclonal antibody, we have identified a 
265-kD polypeptide of the NE that is a rat homologue of the 
previously described human Tpr protein, and have demon- 
strated that it is localized to the cytoplasmic surface of the 
NPC. Several  criteria established that p265 corresponds to 
Tpr.  First, the sequences of seven peptides from p265 and 
its putative proteolytic product p175 were highly homolo- 
gous to sequences of human Tpr, with the extent of incom- 
plete homology being compatible with the rat-human spe- 
cies difference. Second, in vitro translation of human Tpr 
cDNA  yielded a  product that comigrated with rat p265. 
Third, anti-peptide antibodies against human Tpr recognized 
the same rat liver NE antigens as RL30. The RL30-reactive 
bands migrating between 175 and 265 kD in rat liver NEs 
are likely to be in vivo and/or in vitro proteolytic products 
of  p265, as suggested by their variable abundance in different 
preparations and by the predominance of the 265-kD band 
in NRK cells. Further supporting this interpretation, exten- 
sive analysis of human Tpr cDNAs from several  libraries 
does not reveal distinct Tpr-related open reading frames that 
could account for the multiple 175-265-kD species (Mitchell 
and Cooper,  1992a, b). 
In the course of our studies, we identified an error in the 
previously published sequence of human Tpr (Mitchell and 
Cooper,  1992b)  at  codon  2092,  which  causes  a  one- 
nucleotide frameshift and results in a predicted stop three 
codons later. A second distinct open reading frame was pre- 
viously  described  in  the  Tpr  cDNA  that  extends  ,,0250 
residues beyond the originally predicted stop site (Mitchell 
and Cooper, 1992b).  With our sequence correction, the lat- 
ter region is now placed in frame with the main body of the 
Tpr sequence. Thus, the corrected cDNA sequence predicts 
that Tpr is a 2349-residue protein with a molecular mass of 
265,559  D. 
The primary sequence of Tpr indicates the existence of at 
least two separate domains in this polypeptide (Fig. 8; see 
Mitchell and Cooper,  1992b).  Most of the region between 
residues  50  and  1630  contains  heptad  repeats  that  are 
predicted to form a coiled-coil or-helix,  although there are 
several segments ~<50 residues long interspersed throughout 
this region that have low coiled-coil potential (Fig.  8 B). 
This  coiled  coil  domain  is  followed  by  a  700-residue 
hydrophilic domain enriched in acidic residues (16.7% as- 
partic  +  glutamic  acid),  serine  (12.4%),  and  threonine 
(10.4%),  with a predicted isoelectric point of 4.04. Tpr does 
not contain short repeat motifs, which seem to be character- 
istic of the mammalian O-linked glycoproteins (Starr et al., 
1990;  Sukegawa and Blobel, 1993;  Kraemer et al.,  1994). 
The only other characterized NPC protein predicted to form 
a coiled coil or-helix is p62, which contains an •150  residue 
o~-helical region with heptad repeats at its COOH terminus 
(Starr et al., 1990).  The long predicted coiled coil region of 
Tpr could be involved in dimerization, with the protein form- 
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of RL30 antigens and p62 at the end of mitosis. 
NRK cells were processed for double immuno- 
fluorescence staining as in Fig. 4. Fluorescent and 
phase contrast images of cells in metaphase, ann- 
phase, and three progressive stages of telophase 
are shown. Bar, 5 #m. 
ing a myosin-like homotypic dimer of parallel unstaggered 
monomers. 
The ~140-230  NH2-terminal residues of Tpr are found 
in oncogenic fusions with the kinase domains of three differ- 
ent protooncogenes: the receptor tyrosine kinases Met (Park 
et al.,  1986;  Soman et al.,  1991)  and  Trk (Greco et al., 
1992),  as well as the cytoplasmic serine/threonine kinase 
Raf (Ishikawa et al., 1987). How fusion of the amino termi- 
nus of Tpr to tyrosine and serine kinase domains generates 
oncogenic fusion proteins is not entirely clear. One possibil- 
ity is that the amino terminal region of Tpr mediates dimer- 
ization of the kinase domains and thereby mediates kinase 
activation (Rodriguez and Park,  1993; Sawyers and Denny, 
1994). In a second and not mutually exclusive mechanism, 
the amino terminus of Tpr could serve to target the Trk, Raf, 
and Met kinases to the NPC, and this localized concentration 
of kinase activity could modify the functional properties of 
the NPC or of proteins that are transported through the NPC 
(e.g.,  transcription  factors)  to  promote  the  transformed 
state.  Determining whether the Tpr oncogenic fusions are 
targeted to the NPC, and, if so, whether NPC localization 
is required for transformation, should help to resolve this 
issue. 
Localization and Mitotic Dynamics of l~pr 
Immunoblot analysis of subcellular fractions from rat liver 
combined  with  immunofluorescence  staining  of cultured 
cells indicated that Tpr is highly concentrated at the NE. By 
immunfluorescence microscopy, Tpr was  found to have a 
punctate distribution at the NE that largely colocalized with 
NPC marker proteins. Immunogold EM on isolated rat liver 
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Figure 8. Schematic diagram of human Tpr. The 
top diagram shows the predicted domain structure 
of human Tpr (Mitchell and Cooper, 1992b) and 
the bottom plot presents an analysis of the coiled- 
coil potential of Tpr using the program of Lupas 
et al. (1991). This method indicates a higher con- 
tent of coiled-coil in the first 1650 residues of Tpr 
than suggested by a previous analysis (Mitchell 
and Cooper, 1992b). 
NEs confirmed that Tpr is specifically localized to the NPC. 
Interestingly, Tpr was found to be restricted to the cytoplas- 
mic  surface  of the  NPC,  and  was  most concentrated  in 
regions nearby the cytoplasmic ring. This corresponds to the 
NPC region occupied by the cytoplasmic fibrils, which by 
morphological criteria are suggested to be sites where trans- 
port  ligands  initially  associate  or  "dock" with  the  NPC 
(Richardson et al.,  1988;  discussed in Gerace,  1992).  In 
view of the extremely long predicted coiled-coil region of 
Tpr between residues 50 and 1630, we consider it plausible 
if  not likely that Tpr is part of  the backbone of  these cytoplas- 
mic fibrils. 
If the '~1600-residue long a-helical domain of Tpr forms 
a continuous two-stranded c~-helical coiled coil, its length 
would amount to •200  nm (for comparison, see analysis of 
the lamin rod domain discussed in Gerace and Burke, 1988). 
However, because of multiple interruptions in the or-helical 
region of Tpr, it is possible that only a portion of this segment 
forms a two-stranded a-helical coiled coil, or that the region 
contains a number of separate domains of this nature joined 
by flexible linkers. Indeed, four flexible segments within the 
ct-helical domain of Tpr are predicted (Mitchell and Cooper, 
1992b). If the latter structural model is valid, Tpr-based cy- 
toplasmic fibrils could provide a flexibly jointed "arm" in- 
volved in moving transport ligands from their initial docking 
site at the NPC to the central channel complex, a distance 
that may exceed 50-100 nm (discussed in Gerace, 1992). AI- 
ternatively, it is possible that Tpr is not directly involved in 
nuclear import and has some other function related to the ar- 
chitecture of  the NPC or hypothetical interactions with cyto- 
plasmic structures. 
A recent study has identified a 180-kD antigen of the NE 
that is detected in a variety of vertebrate cells with human 
autoimmune antibodies (W'dken et al.,  1993).  In immuno- 
electron microscopy of  isolated NEs ofXenopus oocytes, this 
antigen is localized to the cytoplasmic ring and associated 
fibrils of the NPC, similar to the localization described here 
for Tpr. In view of the properties of this 180-kD antigen, in- 
eluding the  possible  existence of higher molecular mass 
cross-reacting forms suggested by the published immuno- 
blots (Fig.  1 in Wilken et al.,  1993),  we consider it likely 
that this 180-kD antigen corresponds to a proteolytic product 
of ~r. 
We found that when the NE underwent disassembly during 
mitosis Tpr was dispersed throughout the cytoplasm, in a 
similar  fashion to  NPC  proteins  studied  previously  (re- 
viewed by Forbes, 1992; Gerace,  1992).  Interestingly, dur- 
ing the period of NE reassembly at the end of mitosis, Tpr 
associated with the nuclear surface significantly later than 
the O-linked glycoproteins of the NPC including p62.  Al- 
most all of  the I)62 became concentrated at the reforming NE 
by early telophase,  but most Tpr remained diffusely dis- 
tributed throughout the cell at this time. Tpr accumulated at 
the NE only later during mid to late telophase. These results 
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that formation of peripheral  structures containing Tpr fol- 
lows assembly of other components of the NPC including 
p62, which is a part of the approximately twofold symmetri- 
cal structure of the NPC (see below).  However, during the 
period of early telophase when p62 is concentrated at the NE 
in the absence of Tpr, it is not clear whether the p62 is assem- 
bled into a NPC-like structure or into another assembly in- 
termediate. 
Symmetry of the Pore Complex and Nuclear Transport 
In addition to Tpr, some O-linked glycoproteins of the NPC 
have been found to have an asymmetric nuclear/cytoplasmic 
localization.  The CAN protein (yon Lindern et al.,  1992; 
Kraemer et al.,  1994),  as well as an O-linked glycoprotein 
designated p250 (Pant6 et al., 1994), have been shown to oc- 
cur only on the cytoplasmic  surface of the NPC (Kraemer 
et al.,  1994; Pant6 et al.,  1994). p250 corresponds to CAN, 
since it is recognized by polyclonal antibodies raised against 
the  cloned  NH2-  and  COOH-terminal  domains  of  CAN 
(Burke, B., and R. Bastos, personal communication). More- 
over,  the  protein  Nup153  (Sukegawa  and  Blobel,  1993), 
which corresponds to p180 (Snow et al.,  1987), is localized 
exclusively to the nucleoplasmic surface (Snow et al.,  1987; 
Cordes et al.,  1993;  Sukegawa and Blobel,  1993;  Pant~ et 
al.,  1994).  Like  Tpr,  CAN/p250  (Kraemer  et  al.,  1994; 
Pant~ et al.,  1994) has been suggested to be associated with 
the cytoplasmic fibrils, while Nup153/p180 is localized to the 
nucleoplasmic  fibrils (Cordes et al.,  1993) in the terminal 
ring of the nuclear basket  (Pant6 et al.,  1994).  Thus,  the 
nucleoplasmic  and cytoplasmic  fibrils,  which are structur- 
ally distinct peripheral components of the NPC, appear to be 
at least  in part biochemically  distinct.  By  analogy  to the 
putative role of the cytoplasmic fibrils in docking of ligands 
for nuclear import (Richardson et al., 1988), the nucleoplas- 
mic fibrils may have a docking function in nuclear export. 
Apart from the nucleoplasmic and cytoplasmic fibrils, the 
basic ring-spoke  framework of the NPC has twofold sym- 
metry relative to its nucleoplasmic and cytoplasmic "halves" 
(Hinshaw et al.,  1992; Akey and Radermacher,  1993),  and 
these two halves are expected to have similar biochemical 
compositions. The central channel complex has not yet been 
analyzed in detail structurally, but it is plausible that it also 
has twofold symmetry.  At least some of the machinery  for 
nuclear import is suggested to have a twofold symmetrical 
disposition, since the p62 O-linked glycoprotein,  which ap- 
pears to participate directly in nuclear import (Paschal and 
L. Gerace,  manuscript submitted for publication),  is local- 
ized to both the cytoplasmic and nucleoplasmic surfaces of 
the NPC (Cordes et al.,  1991; Guan, T., et al., manuscript 
in preparation).  Thus,  while  initial  ligand  docking  at the 
NPC may involve asymmetric structures that are distinct for 
import  and  export  pathways  (i.e.,  the  cytoplasmic  and 
nucleoplasmic fibrils), many downstream events of transport 
could involve symmetrically arranged machinery that is used 
similarly for both import and export pathways. In this con- 
text, Tpr might provide a valuable focal point for studying 
the structural link between initial and more distal steps of nu- 
clear import at the NPC. 
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